Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual

NCT01995266 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Asunaprevir
DRUG: Daclatasvir

Sponsor

Bristol-Myers Squibb